It is currently accepted that tau overexpression leads to impaired organelle transport and thus to neuronal degeneration. Nevertheless, the underlying mechanisms that lead to impaired organelle transport are not entirely clear. Using cultured Aplysia neurons and online confocal imaging of human tau, microtubules (MTs), the plus-end tracking protein -end-binding protein 3, retrogradely and anterogradely transported organelles, we found that overexpression of tau generates the hallmarks of human tau pathogenesis. Nevertheless, in contrast to earlier reports, we found that the tau-induced impairment of organelle transport is because of polar reorientation of the MTs along the axon or their displacement to submembrane domains. 'Traffic jams' reflect the accumulation of organelles at points of MT polar discontinuations or polar mismatching rather than because of MT depolymerization. Our findings offer a new mechanistic explanation for earlier observations, which established that tau overexpression leads to impaired retrograde and anterograde organelle transport, while the MT skeleton appeared intact.
The cellular and molecular bases of tau-induced neuronal dysfunction and subsequent degeneration have been the subject of intense studies for more than a decade (1) (2) (3) (4) (5) (6) (7) (8) . In an attempt to link tau overexpression, inhibition of axonal transport and neurodegeneration, a molecular cascade was suggested wherein excess tau initially binds to microtubules (MTs) and competes with MT-kinesin-binding sites, thereby downregulating anterograde axoplasmic transport (9) . In turn, tau is overphosphorylated and disengages from the MTs (1). Tau dissociation from MTs increases the MT susceptibility to constitutively active MTsevering proteins, such as katanin and spastin (1, (10) (11) (12) (13) . As a consequence, the MTs undergo accelerated fragmentation and become even more susceptible to depolymerization (14) . Such alterations in MT track integrity lead to reduced organelle transport and subsequently to axonal degeneration (15) .
In a recent study, Thies and Mandelkow (5) proposed an additional cascade, in which overexpression of tau in cultured hippocampal neurons promoted tubulin synthesis, excess MTs polymerization and bundling, followed by MTs disintegration. Tau-mediated neurodegeneration in tauopathies such as in Alzheimer's diseases, frontotemporal dementia with parkinsonism linked to chromosome 17 and Pick's disease for example (6) were also attributed to other mechanisms including gain of toxic functions and mechanical interference with axoplasmic transport (6) . The conclusion drawn from these studies is that impaired transport can be observed in cells both when MT tracks appear intact (16) (17) (18) (19) or when MTs undergo massive depolymerization (5) .
Because MTs are dynamic structures that undergo constant polymerization and depolymerization and as the organization of MTs within a neuron can be dynamically altered in time and space by tau, we undertook here to re-examine dynamic aspects of MTs in neurons overexpressing tau. To that end, we have used online confocal microscope imaging of tau distribution, MTs polarity and vesicle transport in cultured Aplysia neurons.
In contrast to earlier reports, we found that the tau-induced impairment of organelle transport is mainly because of polar reorientation of the MTs along the axon. Organelle 'traffic jams' reflect the accumulation of organelles at pockets formed by MT polar discontinuations or polar mismatching rather than the consequence of MT depolymerization or failure of cargo to translocate along individual MT.
Results
Aplysia's microtubule-associated proteins As baseline information for the present study we examined whether Aplysia neurons express microtubuleassociated proteins (MAPs). Using human tau protein as a query (accession number: P10636), we found two partially overlapping Aplysia expressed sequence tag (EST) (20) . The fused sequence shares homology with a number of human MAPs (when subjected as a pBLAST query). The highest similarity was detected relative to human MAP2 (accession number: AAB33379, identities: 56%, positives: 75%), followed by human tau isoform 3 (accession number: NP_058518, identities: 39%, positives: 53%) and human MAP4 (accession number: BAD92614, identities: 37%, positives: 52%). The EST contains three putative tubulin-binding domains arranged in tandem ( Figure S1C , E-values ranged between 1.9eÀ05 and 6.2eÀ12). These binding repeats are similar to human MAPs. Consistent with the above, we found that tau-5 monoclonal antibody, which recognizes a human tau epitope but does not react with MAP2, and MAP2 monoclonal antibody (which recognizes only high-molecular-weight MAP2 and does not cross-react with human tau) labeled a 100-to 110-kDa protein ( Figure S1A ). This molecular mass is similar to that of the tau-like proteins observed in Drosophila melanogaster and Caenorhabditis elegans (21, 22) .
Comparison between Aplysia MAP (Ap-MAP) EST and different tau and MAP2 orthologs ( Figure S1B ) suggested that as in C. elegans and Drosophila, Ap-MAP represents a common ancestor of tau-MAP2 protein (23) . Higher similarity was detected between Ap-MAP and the Drosophila ortholog than the C. elegans tau ortholog.
These findings indicate that Ap-MAP contains both human tau and MAP2 epitopes. Because Aplysia tubulin reveals a very strong similarity with human tubulin (96% identities, 99% positives for a-tubulin), it is reasonable to assume that exogenous human tau, which harbors MT-binding motifs, will associate with Aplysia MTs.
Characterization of MTs organization and anterograde and retrograde axonal transport in control neurons
To map the dynamic distribution and polarity of MTs in the cultured neurons ( Figure 1A ), we microinjected, into the cell body, messenger RNA (mRNA) encoding green fluorescent protein (GFP)-tagged end-binding protein 3 (EB3), or cherry-tubulin. End-binding protein 3 is an MT plus-end tracking protein, which transiently binds to the plus end of MTs and moves along with their growing tips to form a comet tail-like structure (Movies S1 and S2). This allowed us to confocally image the dynamics and polarity of the MTs (24) (25) (26) . Analysis of online confocal imaging sequences of neurons expressing EB3-GFP (n > 100 neurons) revealed that the majority of the MTs within the main axon and its neurite orient their plus ends distally, toward the tips of the neurites ( Figure 1B ,D and Movie S1). As previously described, the MTs are equally distributed within the axoplasm (27, 28) . In contrast, in the cell body, the MTs plus ends point in various directions (Movie S2). The characteristic polar orientation of the MTs was maintained in cultured neurons for up to 18 days after EB3-GFP-encoding mRNA microinjection. Thereafter, the fluorescent signal of EB3-GFP faded out gradually.
We next characterized the retrograde and anterograde transport of vesicles and mitochondria along the main axon of control neurons (n > 50 neurons). Retrogradely transported pinocytotic vesicles were labeled by bath application of the fluid-phase pinocytotic marker, sulforhodamine 101 (29) . To this end, the neurons were incubated for 20 min in 40 mM SR101, followed by thorough washing with artificial seawater (ASW). Analysis of time-lapse confocal sequences of the SR101-labeled vesicles revealed that the vesicles were retrogradely transported along linear tracks. Consistent with the spatial distribution of the MTs, the retrograde axonal transport occurred across the entire volume of the main axon ( Figure 1C and Movie S3).
To image anterogradely transported Golgi-derived vesicles, we microinjected mRNAs encoding cherry (30) fused at its 3 0 end with SNAP25 [25-kDa synaptosomeassociated protein (31, 32) ] or synaptopHluorin (33) and visualized them 3-4 h later. Earlier studies from our laboratory revealed that injection of mRNA encoding for cherry-SNAP25 or synpH 3-6 h prior to imaging almost exclusively labeled anterogradely transported vesicles (34) . Although individual vesicles could not be discerned, we could positively identify that synpH-labeled vesicles or vesicle aggregates translocate anterogradely along linear tracks ( Figure S2A ). These observations are consistent with the distribution of MTs along the main axon. Likewise, the fluorescent signals of cherry-SNAP25 and synpH were equally distributed across the axon along the MT tracks that occupy the entire axonal volume ( Figure 1F -H).
The motile behavior of mitochondria was imaged by labeling them with the membrane permeable rhodamine B-[(phenanthren-9-yl)aminocarbonyl]benzyl ester (RPAC, 0.5 mM). In control neurons, elongated mitochondria were seen to be anterogradely and retrogradely transported, while a small fraction was stationary ( Figure 1I ).
The spatiotemporal distribution of mutant or wild-type human tau in cultured Aplysia neurons To establish the relationships between the spatiotemporal distribution pattern of wild-type (wt) or mutant tau isoforms within the neurons and the pathological events, we microinjected the cell body of cultured neurons with mRNA encoding GFP-cerulean or cherry-tagged tau. Two human tau constructs, wt tau (À2, À3, þ10) and a double mutant tau [the same isoform, including the two missense mutations K257T and P301S (2)] were used. We selected to use both wt and mutant human tau as it is well established that the neurodegenerative effects of the double mutant tau are more severe than those of the wt (19, 35, 36) and appear to play a role in the pathology of frontotemporal dementias (2, 3) .
Imaging of the fluorescently tagged tau (n ¼ 27 wt and 52 mutant tau-expressing neurons) revealed that the spatiotemporal distribution pattern of both isoforms is similar (see Figure 2 , demonstrating expression of mutant tau). Twenty-four hours following injection, most of the tau fluorescent signal was retained in the cell body cytoplasm, in particular adjacent to the axon hillock (Figure 2A,E) . With time, the fluorescent tau signal increased in the cell body and along the main axon ( Figure 2B ,C,E). Forty-eight to 72 h after cerulean-tau mRNA injection the fluorescent tau reached the tip of the neurites. At approximately 96 h after injection, the tau fluorescence intensity began to decline in the cell body ( Figure 2D ,E). Cerulean-tau fluorescence could be monitored for approximately 10 days.
To examine whether the exogenous human tau associates with the Aplysia MTs, we expressed cherry-tubulin and cerulean-tau and imaged their distribution within a growth cone lamellipodia formed after axonal transection (28) .
Fluorescent profiles of MTs and tau within defined areas were produced and cross-correlated ( Figure 3 ). We found that both the wt and the mutant human tau highly colocalizes with the MTs.
Imaging of neurons expressing human wt and mutant tau revealed that tau overexpression leads to different degrees of pathological alterations in the MTs polar orientation and their displacement. The frequency at which these pathologies were imaged was significantly higher in mutant human tau (80%, n ¼ 52) than in wt human tau (37%, n ¼ 27) expressing neurons. This indicates that, as in vertebrate neurons, the mutant human tau is more effective in causing pathological phenotypes than the wt human tau in cultured Aplysia neurons. A B neuron expressing EB3-GFP for 48 h (F) was imaged 3 h after cherry-SNAP25 mRNA microinjection. The distributions of the cherry-SNAP25 and EB3-GFP intensity profiles (F, G and H) are almost homogenous across the axon, implying that both MTs and anterogradely transported vesicles occupy the entire axonal core. I) The distribution of mitochondria was imaged by RPAC in a B neuron cultured for 72 h. RPAC images were taken 3.9 seconds apart. Fifteen frames were color coded onto a single image. Mitochondria translocate bidirectionally along the axon. White regions denote stationary organelles. Scale bars: 100 mm in A, 10 mm in B, C, G (D) and I.
Below, we describe three pathological phenotypes that differ from each other by their pathological MT orientations and axonal transport. Phenotypes 1 and 2 were most prevalent in neurons expressing lower tau levels than phenotype 3 (for definition of tau levels see Materials and Methods).
Phenotype 1 -transient formation of radial microtubule array within the axon hampers normal axoplasmic transport In a small fraction of neurons (11% wt human tau and 13% mutant human tau) that expressed low levels of exogenous human tau, the formation of one or two tau hotspots was observed within the core of the axon 24-96 h after injection ( Figure 4B ,E). Colocalized with these tau hotspots, we imaged the formation of centrifugally radiating EB3-GFP comet tail structures -microtubule array (MTA) ( Figure 4A 
The formation of MT swirls was positively correlated with a local increase in the tau-cerulean fluorescent intensity compared with the adjacent proximal and distal axonal segments ( Figure S3B ). Imaging of retrogradely transported vesicles labeled with SR101 or anterogradely transported organelles labeled with synaptopHluorins revealed that proximal and distal to the MT swirl the organelles translocate in a normal linear manner along the MTs ( Figure S3E and H). When organelles entered the swollen compartment, they continued to translocate along individual MTs; however, because the MT polar orientation was restructured, multidirectional transport was observed. With time, a substantial fraction of the organelles aggregate within pockets in the swollen region ( Figure 5D and Figure S2C , Movie S7).
The observation that vesicles can translocate along individual MTs within an MT swirl suggests that the individual MT within the swollen axonal segment supports organelle transport. Nevertheless, because of the chaotic polar orientation of the MTs within the swollen region, a fraction of the organelles get 'stuck' within pockets in the MT swirl. These observations suggest that the development of pathological MT swirls causally leads to the gradual buildup of vesicle traffic jams and subsequently to the deterioration of axonal transport.
It is important to note that the mutant tau is significantly more potent in inducing swelling and MT swirls than wt tau (chi-square test; mutant tau versus wt tau; n ¼ 52 and 27 respectively, w 2 ¼ 7.20, p < 0.01).
Phenotype 3 -concentration of tau and MTs in the submembranal region impaired transport and neurodegeneration In 38% of the neurons expressing mutant tau (n ¼ 52) and 22% (n ¼ 27) wt tau-expressing neurons ( Figure 7 ), ceruleantau and MTs concentrated within the axonal cortex 24-72 h after tau mRNA injection ( Figure 6B ,C,E,F,G,K and Movie S8). The MTs at the axonal cortex point their plus ends distally ( Figure 6I ), while at the axonal core, the EB3-GFP comet tails point in various directions ( Figure 6J , Kolmogorov-Smirnov test comparing control with MTs within the core of the axon; n ¼ 200, two-tailed test,
Imaging of SR101-labeled vesicles ( Figure 6D and Movie S9) and mitochondria labeled by RPAC ( Figure 6L ) demonstrated that the transport of these organelle within the axonal core came to a complete halt. Anterograde transport of cherry-SNAP25 and synpH aggregates continued along the MTs within the submembrane domain; however, the axon core was almost devoid of labeled vesicles ( Figure 6F ,H,K and Figure S2D ).
We wish to note that a single neuron can exhibit more than one phenotype.
To study the consequences of tau overexpression on the survival time of cultured neurons, we compared on a daily basis a group of neurons expressing mutant human tau and control neurons (grown in the same dish) that did not express exogenous tau. We found that whereas 85% (n ¼ 13) of the control neurons survived for 11 days (the longest observation time in this series of experiments), neurons that developed pathologies type 2 or 3 revealed signs of degeneration in the form of neurite beading and detachment from the substrate within 8 days.
Estimation of exogenous tau relative to endogenous Ap-MAP expression Interestingly, in most cellular model systems in which exogenous tau overexpression was analyzed, estimates of its expression levels were not provided. To evaluate the relation between the endogenous Ap-MAP and the exogenous human tau isoforms, we selected a group (n ¼ 6) of neurons that express high levels of cerulean-mutant tau (see Materials and Methods, for definition) and a group of control neurons (n ¼ 4) cultured in the same dish, and labeled them with tau-5 antibody, a tau-specific antibody whose epitope maps within the middle of human tau In D-F, a B neuron was microinjected with EB3-GFP and mutant cerulean-tau mRNAs and imaged 24 h later. Elevation of cerulean-tau colocalized with EB3-GFP signal was detected 28 mm distal to the soma (D, E and G). Images of SR101-labeled endocytotic vesicles were taken 5.5 seconds apart. Ten frames were color coded and projected as a single image (F). The merged image demonstrates that retrograde transport of SR101-labeled organelles is normal distal to the site of MTA, whereas at the MTA site, the vesicles were stationary (indicated by the white color code). Proximal to the MTA, the number of SR101-labeled vesicles is reduced, implying that the MTA impairs retrograde axonal transport. Average fluorescent intensity profiles of EB3-GFP, cerulean-tau and SR101 along the axonal length (G) indicate their local elevation is spatially correlated. Scale bars: 10 mm.
protein and recognizes Ap-MAP in Western blots ( Figure  S1A ). The fluorescent intensity and distribution of the labeled endogenous Ap-MAP and exogenous human tau were imaged under identical settings of the confocal system 48 h following tau mRNA microinjection. We found that in control neurons (which express endogenous Ap-MAP only), Ap-MAP immunofluorescent levels slightly increase toward the axon, whereas along the axon, the fluorescent signal intensity remained rather homogeneous ( Figure S4C and E). In contrast, in human tau-expressing neurons (wt and mutant), the total tau immunofluorescent signal (Ap-MAP þ exogenous human tau) formed a decreasing gradient from the axon hillock toward the axonal tip ( Figure S4B and D) . This gradient corresponds to the gradient formed by cerulean-tau ( Figure S4A ). To assess the relative levels of exogenous tau and endogenous Ap-MAP, the ratio of tau-5 fluorescence of mutant human tau-expressing cell and tau-5 fluorescence in control neurons was calculated ( Figure S4F ). The ratio was found to peak at the axon hillock, where it reached a local maximum of 2.37 (n ¼ 6, SD ¼ AE0.51). Along the adjacent axonal segment (300 mm in length), the average ratio was 1.37 (n ¼ 6, SD ¼ AE0.29), while more distally the average ratio was 1.21 (n ¼ 6, SD ¼ AE0.28). Assuming that the affinities of the antibody to the human tau isoform and the endogenous Ap-MAP are not significantly different, and because tau-5 is tau specific and does not cross-react with other MAPs or tubulin, the estimation that was conducted on neurons expressing high tau levels suggests that the pathological alterations already take place at human tau/Ap-MAP ratio below 2.
Discussion
The present study is the first to demonstrate that impaired organelle transport induced by overexpression of human tau is associated with substantial reorganization of MTs polar orientation along the main axon of cultured neurons. Tau-induced 'traffic jams' reflect the accumulation of organelles at points of MT polar discontinuations or polar mismatching rather than consequence of MT depolymerization or failure of molecular motors to function.
Transient formation of MT arrays leads to impaired axoplasmic transport
To the best of our knowledge, this is the first study that reports that tau-induced transient formation of MTA interferes with axoplasmic transport. It is well established that tau promotes MTs polymerization, stabilization and bundling (4,37-39), thus it is reasonable to hypothesize that the injected tau mRNA translocates to the axon and leads to the local buildup of tau concentration. This, in turn, may be sufficient to promote the assembly of MTs that point their plus ends away from the tau hotspot. The MTA transiently impairs the normal traffic of vesicles and thus interferes with the normal functions of the neuron. The spontaneous recovery of the MTA could result from gradual disaggregation of the tau hotspot or may be the outcome of dominating mechanical forces imposed on the MTA by molecular motors.
Because the formation of MTAs may be the first event in a cascade that leads to full-scale tauopathy, we believe that it will be important to examine whether it is present in other systems using the tools described above. Cerulean-tau and EB3-GFP accumulation at the submembrane domain lead to retrograde axonal 'traffic jams' and to neurodegeneration. Forty-eight hours following microinjection of mutant cerulean-tau and EB3-GFP, neuronal beading was evident (A). EB3-GFP comet tails (B, yellow arrows point to the trajectories of the comet tails) and cerulean-tau (C) concentrated at axonal cortex. Average intensity profile plots of cerulean-tau and EB3-GFP reveal that they colocalize and accumulate at the submembranal domain (E). Color coding of endocytotic vesicles labeled by SR101 (10 frames taken 4.6 seconds apart) (D) revealed that the retrograde transport came to a halt within the axonal core, while some transport is retained in the axonal cortex. The distribution of cherry-SNAP25 is documented in a B neuron expressing EB3-GFP (F) and cerulean-tau (G) for 72 h and cherry-SNAP25 for 3 h (H). Cherry-SNAP25 (red), cerulean-tau (blue) and EB3-GFP (green) concentrate and colocalize in the axonal cortex, as evident from the fluorescent intensity profile (K) measured within the rectangles shown in F, G and H. EB3-GFP angle histograms were plotted for the submembranal (I) and axonal (J) regions of the neuron presented in F. For imaging of mitochondria, a B neuron exhibiting accumulation of cerulean-tau and EB3-GFP at the submembrane domain (72 h after injection), was incubated with RPAC. Images were taken 3.5 seconds apart. Fifteen frames were color coded (L). The resulting image reveals cessation of mitochondrial transport. Scale bars: 100 mm in A, 10 mm in D (B, C), H (F, G) and L.
Reorientation of MTs and impairment of axoplasmic transport
A second phenomenon that as far as we know has not been previously reported is that the tau-induced swelling of an axonal segment is associated with the formation of chaotically oriented MT arrays or MT swirls that leads to accumulation of transported vesicles and mitochondria ( Figure 5 and Figure S2C ).
The mechanisms that lead to the formation of the swollen compartment have not been investigated yet. Nevertheless, because we observed that disoriented MTs continued to support organelle transport even in regions that express high levels of fluorescent tau, we suggest that (i) the tau-induced polar reorientation of MTs is not preceded by blockage of the organelle transport mechanisms and (ii) the organelle traffic jams observed at these MT Figure 7 : Rate of development and type of MT orientation pathology as a function of time and human tau isoforms. Cells injected with mutant tau mRNA or wt tau mRNA, and control neurons (not injected with tau encoding mRNA but injected with EB3 mRNA) were imaged during the first 96 h following mRNA microinjection. The phenotype of the neurons was determined by imaging the expression of EB3-GFP. The neurons were classified as normal (corresponding to MT polar orientation as shown in Figure 1 ) or as abnormal (corresponding to the phenotypes depicted in Figures 4-6) . A) While 93% of the control neurons maintained a normal phenotype, 37.04% of the neurons injected with wt tau, and 80.77% of the neurons injected with the mutant tau revealed abnormal phenotypes. All distributions were found to differ significantly from each other (chi-square test; mutant tau versus wt tau: w 2 ¼ 15.1, p < 0.001; mutant tau versus control: w 2 ¼ 40.94, p < 0.001; wt tau versus control: w 2 ¼ 7.54, p < 0.01; the test was performed using raw frequencies). B) Phenotype distributions were created for the neurons shown in A. For the analysis, a neuron exhibiting more than one phenotype during the 4-day observation period was assigned the more severe phenotype (severity level is defined as submembrane concentration of MTs > disordered polarities > MTA). The three distributions significantly differ from each other indicating that they are derived from different populations (chi-square test; mutant tau versus wt tau: w 2 ¼ 16.6, p < 0.001; mutant tau versus control: w 2 ¼ 41.3, p < 0.001; wt tau versus control: w 2 ¼ 9.41, p < 0.025; the test was performed using raw frequencies). C) In order to examine whether there is a difference in the time-course during which MTs assume abnormal orientation or displacement, phenotype distributions were constructed for each day. Mutant tau frequency distributions were compared with each other across time. The first day frequency distribution was found to be significantly altered by the third day (chi-square test; w 2 ¼ 14.45, p < 0.01; test was performed using raw frequencies). Wt tau frequency distribution was not found to significantly different even by the fourth day.
swirls reflect the accumulation of organelles at points of MT polar discontinuation. It is reasonable to assume that as vesicles accumulate at pockets of MT polar mismatching, the region further swells and the local mechanical pressures continue to build up and augment the damages.
Tau translocation to submembranal domain Accumulation of cerulean-tau and EB3-GFP along the axonal cortex became visible 24-72 h after mRNAs injection and was associated with accumulation of SR101-labeled vesicles and mitochondria in the core of the axon. Interestingly, throughout the axonal cortex, the MTs continued to polymerize pointing their plus end distally (as indicated by the EB3-GFP comet tails formation, Movie S8). Correspondingly, SNAP25-associated vesicles colocalized with the EB3-GFP at the submembrane cortex and synpH-containing vesicles appeared to be anterogradely transported along the MT tracks.
The observation of submembranal tau fluorescence accumulation is consistent with earlier studies that revealed that tau interacts with the neuronal plasma membrane (40) . Later studies demonstrated that the src family, nonreceptor tyrosine kinase such as fyn, serves as membrane linkers interacting with tau (41) . It is thus reasonable to assume that translocation of the overexpressed tau to the axonal cortex leads to sequestration of MT fragments into this domain. It is likely also that the tubulin dimers and fragments of MTs are stabilized by the excess tau at the submembrane domain and thus forming dense MTs bundles. These bundles appear to support some retrograde and anterograde vesicles transport (Movies S8 and S9). Nevertheless, as shown by imaging of SR101-labeled vesicles and mitochondria, the bulk of these organelles are concentrated in the axonal core.
Furthermore, Thies and Mandelkow (5) have recently demonstrated a shift between bundling and loss of MTs. This change in MT density is reminiscent of our study, in which we found that initially MTs occupy the entire axonal core, while 24-72 h later, a robust decrease in the axon's core MT density was observed, and during this timecourse, MTs bundle at the cortex.
Mechanisms underlying polar reorientation and translocation of MTs
The mechanisms by which the normal linear polar orientation of MTs is altered by human tau expression in cultured Aplysia neurons were not investigated yet. However, mechanisms of MTs polar reorientation in postmitotic cells were documented in fish melanophores (42, 43) and following mechanical damage to cultured Aplysia neurons (34) . Following mechanical injury of these cells, the MTs undergo a cycle of fragmentation and repolymerization, which culminates in altered MT polar reorientation. Two mechanisms have been offered to explain the reorientation of MTs. (i) Minus-end-oriented motors associate simultaneously with two or more MT fragments. The motor simultaneously drives the MTs in respect to each other, leading to polar reorientation of the two MT fragments. (ii) The second model assumes that MT fragments cannot be rotated through the cytoplasm (but can treadmill) and that the reorientation results from de novo MT polymerization. In both models, the first step for MT polar reorientation involves fragmentation or depolymerization.
It is interesting to recall that tau overexpression leads to its phosphorylation and detachment from MTs (1), thus exposing the MTs to severing proteins that locally fragment the MTs (1, 14) . It is reasonable to assume that in consequence, the parallel alignment and anchorage of MTs to one other and to other cytoskeletal elements are disrupted. Under these conditions, MT fragments lose their directional positioning and the regulatory proteins and molecular motors that normally operate to maintain the normal MT polar orientation are misplaced or absent. Thus, the MTs are free to elongate in various directions and form MTAs and MT swirls or translocate to the plasma membrane.
The documentation of tau-induced pathological reorientation of MT in cultured Aplysia neurons, followed by the subsequent impairment of organelle transport and degeneration justify a reappraisal of whether vertebrate neurons generate similar phenotypes using the tools and concepts developed in the present study.
General implications
A major observation of this study is that overexpression of human tau in cultured Aplysia neurons leads to a characteristic sequence of pathological alterations similar to those reported from studies of vertebrate and invertebrate models. These include swelling of axonal segments (44) , translocation of tau to submembrane domains (40) , impaired organelle transport (18) , compromised neurite morphology (35) and degeneration (19) . Furthermore, just as in vertebrate models, the frequency at which these pathologies occurred was significantly higher in neurons expressing mutant human tau (80%, n ¼ 52) than in neurons expressing wt human tau (37%, n ¼ 27) ( Figure 7A ). This, together with the observation that overexpression of other cytoskeleton-related human genes (tubulin, actin, kinesin), did not induce any detectable pathologies, indicating that the observed alterations are related to human tau expression. Our estimates of the human tau levels that are sufficient to elicit pathological MT reorientations revealed that human tau/Ap-MAP ratio, lower than 2, is sufficient (phenotypes 1 and 2).
A comparison of human and Aplysia a-and b-tubulin 2 sequences resulted in 96-98% identities. These similarities suggest that the interaction between the ectopically expressed human tau isoforms in Aplysia neurons can Traffic 2008; 9: 458-471mimic tau-MTs interactions in vertebrate neurons. Consistent with this view, our study (Figure 3 ) revealed clear colocalization of the human tau and fluorescently labeled MTs. Because the three consensus sequences comprising MT-binding domains arrayed in tandem were detected within the Aplysia EST database, it is reasonable to assume that ectopic human tau competes with the endogenous Ap-MAP for MT-binding sites. This accounts for the pathological similarities that we documented in the Aplysia model to pathologies reported in studies of vertebrate neurons.
In conclusion, the data presented in this study suggest that the use of cultured Aplysia neurons as a cellular platform to study the cell biology of tau overexpression is beneficial.
Materials and Methods

Cell culture
Neurons B1 and B2 from the buccal ganglia of Aplysia californica (Aplysia Resources Facility, Miami, Florida) were isolated and maintained in culture as described previously (45, 46) . In the present study, we refer to buccal neurons 1 and 2 collectively as B neurons.
Culture medium
The culture medium consisted of 10% filtered hemolymph, obtained from Aplysia fasciata collected in the Mediterranean, diluted in modified Leibovitz's L 15 Medium as described previously (46) .
Chemicals and pharmacological reagents
The fluid-phase pinocytotic marker -sulforhodamine 101 (SR101; Kodak) -was prepared as a stock solution of 10 mM in double distilled water and further diluted before use in ASW to a final concentration of 40 mM. Imaging of retrogradely transported pinocytotic vesicles labeled by SR101 was performed as described by Erez et al. (34) .
Mitochondria were labeled by rhodamine B-[(phenanthren-9-yl)aminocarbonyl]benzyl ester (RPAC -a gift of Professor Ioav Cabantchick, the Hebrew University). RPAC was prepared as a 3.84 mM stock solution in dimethyl sulfoxide and further diluted in the experimental dish to a final concentration of 0.5 mM.
Messenger RNA preparation and injection
The mRNAs were transcribed in vitro using the recombinant transcription system, as described by our laboratory (47) . GFP-tagged EB3 (25, 48) ; GFP-, cerulean-or cherry-tagged wt or double mutant tau (provided by Dr H. Rosenmann, Hadassah University Hospital, Ein-Karem, Jerusalem, Israel) containing both missense mutations P301S and K257T (49-51); and cherry-SNAP25 (A. californica SNAP25 was provided by W.S. Sossin, Montreal University, Montreal, Canada) were cloned in pCS2þ expression vector as previously described (47) .
The transcribed mRNAs were pressure injected into the cell body cytoplasm of cultured neurons 4-24 h after plating, as previously described (47) .
Identification of AP-MAPs
A characteristic of tau and MAP2 is their solubility following a brief exposure to high temperatures of 90-1008C (52, 53) . Heat-stable MAPs were prepared from rat brain and Aplysia central nerve system extracts that were brought to a final concentration of 0.7 M NaCl and boiled for 5 min. Samples were then centrifuged for 15 min at 48C, and the supernatant containing the heat-stable protein was analyzed by Western blot analysis using tau-and MAP2-specific antibodies (tau-5, polyclonal tau and MAP2; the same antibodies are used by us to immunolabel the proteins in situ). Samples were run on 10% sodium dodecyl sulfate gels.
Confocal microscope imaging
The systems used for confocal imaging included a Nikon C1 confocal system mounted on a Nikon TE-2000 Eclipse microscope system with a Nikon plan-Apo chromat 60Â 1.4 NA oil objective. This system was equipped with three lasers: blue diode (405 nm), argon (488 nm) and green HeNe (543 nm). Images were collected and processed using EZ-C1 software at 20-248C.
GFP-tagged proteins were excited at 488nm, and the emitted fluorescence was collected using a 515/30 nm filter. Cherry-tagged proteins were excited using the 543 nm laser, and emission was collected using 605/75nm filter. Cerulean-tagged proteins were excited using the 405 nm laser, and emission was collected with a 450/35nm filter. SR101 was excited with the 543 nm laser, and the emission was collected through a 605/75nm filter.
Color coding of SR101 or RPAC time-lapse sequences was achieved as follows: consecutive images within a time-lapse series were colored from blue to red. The individual images were then projected to produce a single image in which a moving organelle changes its color as a function of time. Immobile objects appear white reflecting the summation of the rainbow.
Imaging of anterogradely transported vesicles
Anterogradely transported vesicles were labeled by intracellular injection of mRNA encoding superecliptic synaptopHluorin (33) 3-4 h before imaging. The short time interval between mRNA injection and imaging ensured that the fluorescent probes labeled newly anterogradely transported vesicles almost exclusively rather than recycled, retrogradely transported plasma membrane vesicles.
Image analysis
Images were analyzed offline using NIH IMAGEJ software and MATLAB (MathWorks) and LASERPIX (Media Cybernetics, L.P.). The figures were prepared using Photoshop (Adobe Systems) and FREEHAND software (Macromedia).
For demonstrating the average intensity along or across the axon a suitable rectangle was selected over the relevant region, wherein the average fluorescence intensity of a vertical (y-axis) row of pixels was plotted as a function of length (x-axis) using MATLAB.
Estimate of the expression level of exogenous cerulean-tau
Estimation of the ratio: exogenous human tau to endogenous Aplysia MAP The ratio of endogenous Ap-MAP and the exogenous human tau expressed by the neurons was estimated as follows: mRNA encoding human tau was microinjected into the cell body of a neuron (experiment), while a second neuron cultured in the same dish served as the a control. Forty-eight hours later, both neurons were fixed and prepared for immunolabeling as previously described (54, 55) . The neurons were then labeled with tau-5 antibody (1:500), followed by Cy-2-conjugated a-mouse antibody (1:50; Jackson Immunoresearch). The total immunofluorescent signal of the experimental neurons (that expressed the endogenous Ap-MAP and the exogenous human tau) and the control neuron (expressing only the endogenous tau) were imaged using identical settings of the confocal microscope system [plan-Apo chromat 60Â 1.4 NA oil objective, argon laser (403 nm) at 25% intensity, 100 mm pinhole setting and gain of 122 arbitrary units (AU)]. Thereafter, fluorescent intensity profiles of the control and experimental neurons were constructed. The ratio of the profiles was calculated at the cell body axon hillock and along the main axon ( Figure S4 ).
Correlation between tau levels and the pathological phenotypes
To quantitively relate the concentration of exogenous human tau expressed in the neurons to its cellular effects, we retrospectively subdivided the neurons in to two groups according to the relative fluorescence intensity of cerulean-tau. To that end, the cerulean-tau fluorescence intensity was always measured 48 h after injection using plan-Apo chromat 60Â 1.4 NA oil objective, blue diode laser (403 nm) at 100% intensity, 100 mm pinhole setting and the gain level was constantly set at 122 AU. Based on our results, we defined low cerulean-tau as 16.4 AE 2.9 fluorescence AU, and high cerulean-tau as more than twice the averaged low fluorescence (36.1 AE 3.5 AU). Accordingly, neurons revealing at 48 h after mRNA injection 5-20 AU were defined as expressing low cerulean-tau concentration and those above this value as highly expressing. In order to produce high-quality images of cerulean-tau, three frames of tau were taken sequentially and automatically averaged using the EZ-C1 software.
We found that phenotypes 1 and 2 could be correlated with relative lower tau levels. Phenotype 3 was seen most often when high tau levels were detected. The fluorescent intensities in the two groups were found to differ significantly using the Mann-Whitney U-test (n ¼ 7, two-tailed test, a ¼ 0.05, p ¼ 0.023).
Analysis of Aplysia MAP -MT colocalization
Flat growth cone lamellipodia of B cells expressing cerulean-tau and cherrytubulin were imaged. Fluorescent profiles of MTs and tau were formed and cross-correlated using the MATLAB routine xcorr, and the Pearson's correlation coefficient was calculated.
Quantification of the MTs polarity
The directionality of single EB3-GFP-labeled MT was defined using image processing, which included the following main steps: (i) an area of interest (AOI) was defined; (ii) the frames were converted into binary images, such that EB3-labeled fluorescent 'comet tails' were separated from the background; (iii) the directionality of a single comet tail was defined by comparing its position in two consecutive frames, providing a movement vector of individual comet tails and (iv) an angle histogram of 100 comet tails within the AOI was produced. The MATLAB script developed by us is available online (see online supplementary text file).
Statistical analysis and sequence similarity
To determine the significance of alteration in MT polar orientation as revealed by imaging of the EB3 comet tails, we used the nonparametric MannWhitney U-test and the Kolmogorov-Smirnov test. The tests were performed using MATLAB. To compare MT orientation phenotype distributions, we used the chi-square test. In order to assign a phenotype to a neuron throughout a period of 4 days, cells were imaged and the severest phenotype recognized throughout this period was assigned. Submembrane translocation of MTs was considered as the most severe phenotype, followed by disordered MTs orientation and MTA. Sequence similarity was assessed using BLAST (NCBI). Conserved domains were found using PFAM. Figure S2 : Tracing of synaptopHluorin-labeled vesicle aggregates transport in mutant tau-expressing neurons. A) A control cell cultured for 72 h was microinjected with synaptopHluorin mRNA and imaged, using 488 nm excitation wavelength, 3 h after injection. The synaptopHluorinlabeled aggregates, which occupy the entire cross-section of the axon, translocate anterogradely along linear tracks. B) An MTA was observed in a neuron expressing mutant tau for 24 h. At the site of the MTA (left side of diagram), we observed nonlinear trajectories of aggregates (C). A neuron expressing mutant tau for 48 h developed stereotypic axonal swelling. Trajectories of vesicular aggregates translocation within the swollen region were highly disordered, whereas more distally along the axon they translocated anterogradely along linear tracks. D) A neuron expressing mutant tau for 72 h and revealed submembranal concentration of tau was injected with synaptopHluorin mRNA. Vesicular aggregates were observed to translocate anterogradely predominately along the axonal cortex. In contrast within the core of the axon, the vesicular aggregates translocated in various directions. Scale bars: 10 mm. Movies S8: Accumulation of EB3 at the submembranal domains. The movie relates to Figure 6 . A B neuron characterized by accumulation of tau at the submembranal domains is shown. The EB3-GFP comet tails reside mainly along the axonal cortex, some EB3-GFP comet tails at the axonal core point their plus ends in various directions. The movie comprises 45 images, taken at intervals of 4.6 seconds. The frames are shown at a rate of 10 per seconds. Scale bars: 10 mm.
Movie S9: Accumulation of EB3 at the submembranal domains. The movie relates to Figure 6 . Pinocytotic retrogradely transported vesicles labeled by SR101 is portrayed. While the transport of SR101-labeled vesicles came to a halt within the axonal core, some transport is retained at the axonal cortex. The movie comprises 45 images, taken at intervals of 4.6 seconds. The frames are shown at a rate of 10 per seconds. Scale bars: 10 mm.
Original movies are available now online at http://www.spiralab.huji.ac.il/ Shemesh.Traffic.htm Supplementary text file: Supplemental MATLAB script -Quantification of movement directionality of EB3-GFP 'comet tails'. The following script can be copied into a MATLAB script editor.
Supplemental materials are available as part of the online article at http:// www.blackwell-synergy.com
